Here are the five most popular gastroenterology and endoscopy stories for the week of Sept. 6 to Sept. 12, 2018:
GI & Endoscopy
Bausch Health and Salix Pharmaceuticals settled outstanding intellectual property claims against their drug Xifaxan from generic drugmaker Actavis Laboratories.
The Bruce and Cynthia Sherman Charitable Foundation awarded three 2018 Sherman Prizes to Pittsburgh-based UPMC's David Binion, MD, New York City-based Mount Sinai Hospitals' Jean-Frederic Colombel, MD, and Rochester, Minn.-based Mayo Clinic's Amy Lightner, MD.
The World Health Organization released new cancer tracking numbers, finding colorectal cancer is the third most common cancer in the world and the second deadliest, CNN reports.
Donald J. Martin, MD, is a gastroenterologist at Overland Park, Kan.-based Gastrointestinal Associates.
Here are seven updates on GI companies from the past week:
Steven Brown, MD, will receive the Humanitarian of the Year award from the Crohn's & Colitis Foundation's Connecticut chapter at the group's "Bottoms Up" event, Nov. 2 in Hartford, Conn, we-ha.com reports.
The American Gastroenterological Association received National Institutes of Health funding to support its AGA Forward Program.
Takeda will close its U.S. headquarters in Deerfield, Ill., and move the work to Boston, the Chicago Tribune reports.
Luxembourg City, Luxembourg-based University of Luxembourg researchers discovered the mechanism they believe is responsible for the spread of colon cancer cells and metastasis development.
